Test-retest repeatability and software reproducibility of myocardial flow measurements using rest/adenosine stress Rubidium-82 PET/CT with and without motion correction in healthy young volunteers
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Test-retest repeatability and software reproducibility of myocardial flow measurements using rest/adenosine stress Rubidium-82 PET/CT with and without motion correction in healthy young volunteers. / Byrne, Christina; Kjær, Andreas; Olsen, Naja Enevold; Forman, Julie Lyng; Hasbak, Philip.
I: Journal of Nuclear Cardiology, Bind 28, 2021, s. 2860–2871.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Test-retest repeatability and software reproducibility of myocardial flow measurements using rest/adenosine stress Rubidium-82 PET/CT with and without motion correction in healthy young volunteers
AU - Byrne, Christina
AU - Kjær, Andreas
AU - Olsen, Naja Enevold
AU - Forman, Julie Lyng
AU - Hasbak, Philip
PY - 2021
Y1 - 2021
N2 - BackgroundMyocardial flow reserve (MFR) assessment with cardiac positron emission computed tomography (PET/CT) is well established, and quantification relies on commercial software packages. However, for reliable use, repeatability and reproducibility are important. The aim of this study was therefore to investigate and compare between scans and software packages the repeatability and reproducibility of 82Rb-PET/CT estimated MFR.Methods and ResultsForty healthy volunteers completed two 82Rb-PET/CT rest and adenosine stress scans. syngo.MBF (Siemens), quantitative-gated SPECT (QGS) (Cedars-Sinai), and Corridor4DM (4DM) were used for analyses. Motion correction was available for 4DM. Fifty percent were men and age was 24 ± 4 years (mean ± SD). Repeatability of MFR varied between scans. syngo.MBF: mean difference (95% CI) 0.26 (− 0.03 to 0.54), P = 0.07, limits of agreement (LoA): − 1.43 to 1.95; QGS: 0.19 (− 0.08 to 0.46), P = 0.15, LoA: − 1.38 to 1.76; 4DM: 0.08 (− 0.17 to 0.34), P = 0.50, LoA: − 1.37 to 1.53; and 4DM motion corrected: 0.17 (− 0.17 to 0.51), P = 0.32, LoA: − 1.89 to 2.22. MFR was higher using 4DM +/− motion correction compared with syngo.MBF and QGS (all P < 0.0001). Concordance between syngo.MBF and QGS was high (P = 0.83).ConclusionsReproducibility of MFR varied for the different software. The highest concordance between MFRs was found between syngo.MBF and QGS.
AB - BackgroundMyocardial flow reserve (MFR) assessment with cardiac positron emission computed tomography (PET/CT) is well established, and quantification relies on commercial software packages. However, for reliable use, repeatability and reproducibility are important. The aim of this study was therefore to investigate and compare between scans and software packages the repeatability and reproducibility of 82Rb-PET/CT estimated MFR.Methods and ResultsForty healthy volunteers completed two 82Rb-PET/CT rest and adenosine stress scans. syngo.MBF (Siemens), quantitative-gated SPECT (QGS) (Cedars-Sinai), and Corridor4DM (4DM) were used for analyses. Motion correction was available for 4DM. Fifty percent were men and age was 24 ± 4 years (mean ± SD). Repeatability of MFR varied between scans. syngo.MBF: mean difference (95% CI) 0.26 (− 0.03 to 0.54), P = 0.07, limits of agreement (LoA): − 1.43 to 1.95; QGS: 0.19 (− 0.08 to 0.46), P = 0.15, LoA: − 1.38 to 1.76; 4DM: 0.08 (− 0.17 to 0.34), P = 0.50, LoA: − 1.37 to 1.53; and 4DM motion corrected: 0.17 (− 0.17 to 0.51), P = 0.32, LoA: − 1.89 to 2.22. MFR was higher using 4DM +/− motion correction compared with syngo.MBF and QGS (all P < 0.0001). Concordance between syngo.MBF and QGS was high (P = 0.83).ConclusionsReproducibility of MFR varied for the different software. The highest concordance between MFRs was found between syngo.MBF and QGS.
KW - Myocardial perfusion
KW - Myocardial blood flow
KW - Myocardial flow reserve
KW - Positron emission tomography
KW - Repeatability
KW - Reproducibility
U2 - 10.1007/s12350-020-02140-1
DO - 10.1007/s12350-020-02140-1
M3 - Journal article
C2 - 32390111
VL - 28
SP - 2860
EP - 2871
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
SN - 1071-3581
ER -
ID: 241574359